Radiobiological characterization of post-lumpectomy focal brachytherapy with lipid nanoparticle-carried radionuclides

Physics in Medicine and Biology

Volumn 56, Issue 3, 2011, Pages 703-719

  Hrycushko, Brian A ^a   Gutierrez, Alonso N ^a   Goins, Beth ^a   Yan, Weiqiang ^a   Phillips, William T ^a   Otto, Pamela M ^a   Bao, Ande ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORBED DOSE; ACTIVITY CONCENTRATION; ACTIVITY DISTRIBUTION; BRACHYTHERAPY; DOSE DELIVERY; EARLY-STAGE BREAST CANCER; EXTERNAL BEAM RADIOTHERAPY; KERNEL CONVOLUTION; LIPID NANOPARTICLES; NORMAL TISSUE; PRIMARY OBJECTIVE; RESIDUAL DISEASE; SAMPLE TREATMENT; STIMULATORY EFFECTS; THERAPEUTIC RANGE; TUMOR GROWTH; WOUND HEALING;

CONVOLUTION; LIPOSOMES; NANOPARTICLES; ONCOLOGY; PHOSPHOLIPIDS; RADIOISOTOPES;

RADIOTHERAPY;

LIPOSOME; RADIOISOTOPE; RHENIUM;

ANIMAL; ARTICLE; BRACHYTHERAPY; BREAST; CELL TRANSFORMATION; CHEMISTRY; HEAD AND NECK TUMOR; HUMAN; KIDNEY; METHODOLOGY; ORGANS AT RISK; PATHOLOGY; PROBABILITY; RADIATION EXPOSURE; RADIOBIOLOGY; RADIOMETRY; RAT; SEGMENTAL MASTECTOMY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; BRACHYTHERAPY; BREAST; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; KIDNEY; LIPOSOMES; MASTECTOMY, SEGMENTAL; ORGANS AT RISK; PROBABILITY; RADIOBIOLOGY; RADIOISOTOPES; RADIOMETRY; RATS; RHENIUM; TREATMENT OUTCOME;

EID: 79551695288     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/56/3/011     Document Type: Article

References (49)

1. Alexander M A R, Brooks W A and Blake S W 2007 Normal tissue complication probability modeling of tissue fibrosis follo (Pubitemid 46646349)
2. Bao A, Phillips W T, Goins B, Zheng X, Sabour S, Natarajan M, Woolley F R, Zavaleta C and Otto R A 2006 Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection Int. J. Pharm. 316 162-9 (Pubitemid 43765700)
3. Bao A, Zhao X, Phillips W T, Woolley F R, Otto R A, Goins B and Hevezi J M 2005 Theoretical study of the influence of a heterogeneous activity distribution on intratumoral absorbed dose distribution Med. Phys. 32 200-8 (Pubitemid 40165532)
4. Begg A C and Terry N H 1984 The sensitivity of normal stroma to fractionated radiotherapy measured by a tumour growth rate assay Radiother. Oncol. 2 333-41 (Pubitemid 15166544)
5. Begg A C et al 1999 The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis Radiother. Oncol. 50 13-23
6. Belletti B et al 2008 Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding Clin. Cancer Res. 14 1325-32 (Pubitemid 351413911)
7. Bentzen S M et al 2008 The UK Standardization of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial Lancet Oncol. 9 331-41
8. Blichert-Toft M, Nielson M, During M, Moller S, Rank F, Overgaard M and Mouridsen H T 2008 Long-term results of breast conserving surgery versus mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol Acta Oncol. 47 672-81 (Pubitemid 351878447)
9. Bondiau P Y, Bahadoran P, Lallement M, Birtwisle-Peyrottes I, Chapellier C, Chamorey E, Courdi A, Quielle-Roussel C, Thariat J and Ferrero J 2009 Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumors Int. J. Radiat. Oncol. Biol. Phys. 75 1041-7
10. Bovi J, Qi S X, White J and Li X A 2007 Comparison of three accelerated partial breast irradiation techniques: treatment effectiveness based upon biological models Radiother. Oncol. 84 226-32 (Pubitemid 47362401)
11. Burrows T W 1988 The program RADLST Report BNL-NCS-52142 (Upton, NY: Brookhaven National Laboratory)
12. Butler W M, Stewart R R and Merrick G S 2009 A detailed radiobiologic and dosimetric analysis of biochemical outcomes in a case-control study of permanent prostate brachytherapy patients Med. Phys. 36 776-87
13. Chu M, Zhuo S, Xu J, Sheng Q, Hou S and Wang R 2010 Liposome-coated quantum dots targeting the sentinel lymph node J. Nanopart. Res. 12 187-97
14. Dale R 2004 The use of the linear-quadratic radiobiological model for quantifying kidney response in targeted radiotherapy Cancer Biother. Radiopharm. 19 363-70 (Pubitemid 38924502)
15. Dawson L A, Kavanagh B D, Paulino A C, Das S K, Miften M, Li X A, Pan C, Ten Haken R K and Schultheiss T E 2010 Radiation-associated kidney injury Int. J. Radiat. Oncol. Biol. Phys. 76 S108-15
16. Ebert M A 2000 Viability of the EUD and TCP concepts as reliable dose indicators Phys. Med. Biol. 45 441-57 (Pubitemid 30096774)
17. Fisher B, Anderson S, Bryant J, Margolese R G, Deutsch M, Fisher E R, Jeong J and Wolmark N 2002 Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N. Engl. J. Med. 347 1233-41 (Pubitemid 35176242)
18. Furhang E E, Sgouros G and Chui C S 1996 Radionuclide photon dose kernels for internal emitter dosimetry Med. Phys. 23 759-64 (Pubitemid 26155174)
19. Gabizon A A 2007 Applications of liposomal drug delivery systems to cancer therapy Nanotechnology for Cancer Therapy ed M MAmiji (Boca Raton, FL: CRC Press) pp 595-611
20. Graham P and Fourquet A 2006 Placing the boost in breast-conservation radiotherapy: a review of the role, indications and techniques for breast-boost radiotherapy Clin. Oncol. (R. Coll. Radiol.) 18 210-9 (Pubitemid 43264357)
21. Guerrero M and Li X A 2003 Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning Phys. Med. Biol. 48 3307-26 (Pubitemid 37321554)
22. Gump F E 1992 Multicentricity in early breast cancer Semin. Surg. Oncol. 8 117-21
23. Harrington K J, Rowlinson-Busza G, Syrigos K N, Uster P S, Vile R G and Stewart J S 2000 Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery Clin. Cancer Res. 6 2528-37 (Pubitemid 30399225)
24. Hockel M and Dornhofer N 2005 The hydra phenomenon of cancer: why tumors recur locally after microscopically complete resection Cancer Res. 65 2997-3002 (Pubitemid 40524574)
25. Holland R, Connolly J L, Gelman R, Mravunac M, Hendriks J, Verbeek A, Schnitt S J, Silver B, Boyages J and Harris J R 1990 The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast J. Clin. Oncol. 8 113-8 (Pubitemid 20032453)
26. Holland R, Veling S H, Mravunac M and Hendriks J 1985 Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery Cancer 56 979-90 (Pubitemid 15003474)
27. Howell R W, Goddu S M and Rao D V 1994 Application of the linear-quadratic model to radioimmunotherapy: further support for the advantage of longer-lived radionuclides J. Nucl. Med. 35 1861-9 (Pubitemid 24346813)
28. Hrycushko B A, Li S, Shi C, Goins B, Liu Y, Phillips W T, Otto P M and Bao A 2010 Postlumpectomy focal brachytherapy for simultaneous treatment of surgical cavity and draining lymph nodes Int. J. Radiat. Oncol. Biol. Phys. 2010 Sep. 23
29. International Commission on Radiological Protection (ICRP) 1979 Limits for intakes of radionuclides by workers. ICRP Publication 30 Part 1 Ann. ICRP 2 (3/4)
30. Kawrakow I and Rogers D W 2000 The EGSnrc code system: Monte Carlo simulation of electron and photon transport Technical Report PIRS-701 (Ottawa: National Research Council of Canada)
31. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H and Adami H O 1999 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial J. Clin. Oncol. 17 2326-33 (Pubitemid 29368230)
32. Lyman J T 1985 Complication probability as assessed from dose volume histograms Radiat. Res. 104 S13-9 (Pubitemid 16149302)
33. Mainegra-Hing E, Rogers D W and Kawrakow I 2005 Calculation of photon energy deposition kernels and electron dose point kernels in water Med. Phys. 32 685-99 (Pubitemid 40411469)
34. Mannino M and Yarnold J 2009 Effect of breast-duct anatomy and wound healing responses on local tumour recurrence after primary surgery for early breast cancer Lancet Oncol. 10 425-9
35. Motomura K, Koyama H, Noguchi S, Inaji H, Kasugai T and Nagumo S 1999 Malignant seeding of the lumpectomy cavity upon breast-conserving surgery Oncology 57 121-6 (Pubitemid 29385489)
36. Niemierko A 1997 Reporting and analyzing dose distributions: a concept of equivalent uniform dose Med. Phys. 24 103-10 (Pubitemid 27051935)
37. Oussoren C and Storm G 2001 Liposomes to target the lymphatics by subcutaneous administration Adv. Drug Deliv. Rev. 50 143-56 (Pubitemid 32727280)
38. Rischin D, Peters L, Fisher R, Macann A, Denham J, Poulsen M, Jackson M, Kenny L, Penniment M, Corry J, Lamb D and McClure B 2005 Tirapazamine, Cisplatin, and radiation versus Fluorouracil, Cisplatin, and radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02) J. Clin. Oncol. 23 79-87 (Pubitemid 41702625)
39. Rogers D W, Kawrakow I, Seuntjens J P, Walters B R B and Mainegra-Hing E 2005 NRC user codes for EGSnrc Technical Report PIRS-702 (Ottawa: National Research Council of Canada)
40. Sabel M S, Rogers K, Griffith K, Jagsi R, Kleer C G, Diehl K A, Breslin T M, Cimmino V M, Chang A E and Newman L A 2009 Residual disease after re-excision lumpectomy for close margins J. Surg. Oncol. 99 99-103
41. Simpkin D J and Mackie T R 1990 EGS4 Monte Carlo determination of the beta dose kernel in water Med. Phys. 17 179-86 (Pubitemid 20140135)
42. Stabin M G and da Luz L 2002 Decay data for internal and external dose assessment Health Phys. 83 471-5 (Pubitemid 35015004)
43. Tagliabue E et al 2003 Role of HER2 in wound-induced breast carcinoma proliferation Lancet 362 527-33 (Pubitemid 36980657)
44. Tobias J S, Vaidya J S, Keshtgar M, Douek M, Metaxas M, Stacey C, Sainsbury R, D'Souza D and Baum M 2006 Breast-conserving surgery with intra-operative radiotherapy: the right approach for the 21st century? Clin. Oncol. (R. Coll. Radiol.) 18 220-8 (Pubitemid 43264358)
45. Tome W A and Fowler J F 2002 On cold spots in tumor subvolumes Med. Phys. 29 1590-8 (Pubitemid 34774592)
46. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M and Marubini E 2002 Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer N. Engl. J. Med. 347 1227-32 (Pubitemid 35176241)
47. Wang S X, Bao A, Herrera S J, Phillips W T, Goins B, Santoyo C, Miller F R and Otto R A 2008 Intraoperative 186Re-liposome radionuclide therapy in a head and neck squamous cell carcinoma xenograft positive surgical margin model Clin. Cancer Res. 14 3975-83
48. Webb S and Nahum A E 1993 A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density Phys. Med. Biol. 38 653-66 (Pubitemid 23188329)
49. Wyatt R M, Jones B J and Dale R G 2008 Radiotherapy treatment delays and their influence on tumour control achieved by various fractionation schedules Br. J. Radiol. 81 549-63 (Pubitemid 351957741)